Member Info for ForFXSake

Which is pretty convenient, I suppose, given the apparent lack of progress on sealing some kind of partnership deal

This is a prime example of how the company's only contingency is to raise more funds rather than plan an alternative strategy.

They got EMA ODD in May last year with whatever benefits that offers. They could have used it to strike a partnership deal. We are now in February, just 3 months away from that anniversary, at which point we will probably have lost a year of those benefits.

Despite having the opportunity to use the EMA to strike a deal, they have instead opted to go high risk by putting all their eggs in one basket hingeing on FDA approval. This is now going to cost shareholders further dilution with no reinforced evidence that it will result in a partnership deal. If it fails then it will look bad and not help partnership discussions beyond what we had a year ago.

I hope for all our sakes it turns out to have been worth it. Personally, I would much rather be in a position where we are closer to striking a realistic partnership deal on the back of EMA than chasing shadows like we appear to be doing now.

All we seem to have done so far is bought more time for our competitors and any vultures out there waiting to take everything off us for nothing.

"so there is progress"

Just keep telling yourself that

Too much of it

You welcome more dilution for absolutely zero progress? You'll fit in well here.

..as there is still no news, is all this volume down to them working the placing before it's announced?

While the dumping actually happens

I'm finding it increasingly hard to believe that they haven't been given a decision by the FDA without some explanation or reason as to why it has taken nearly twice the normal processing time.

I'm also interested to know why shareholders who are about to be asked for more money to proceed with 'partnership discussions' haven't been given any information whatsover about what has been achieved so far in the discussions that are supposed to have been happening over the past 2 years.

Where are the partners?

It's arguable, I suppose.

I took the EU ratification to be the formal EU confirmation. The 29th April was COMP signalling a positive opinion. However, it had not been formally ratified and so was still at risk of rejection on a technicality, although probably slight.

Why did they just not wait for that?

Yes sorry, I meant 22nd May (not April) for the placing and 29th May for ODD Confirmation

"Ok, just strange that you would want put it out there that they would look to do that when they haven't said they would"

Why is it strange? Isn't that what they did last time? RNS for fundraise on 22nd April followed by ODD RNS on 29th?

Is it not strange that they chose to initiate a fundraise without the backing of the confidence offered to investors by the ODD ratification? Wasn't that likely to drive the price down?

No they didn't, why is why I said "I guess we'll see"

Well, I respect your opinion OSD (as I do everyone's here) but I would find it very strange to want to raise funds before that FDA decision is released, if they are still expecting it to be positive.

I guess we'll see

"It's harden to pin down why investors have been so cowardly"

Is it that hard to understand?

We are now almost 6 months into an FDA review that should only have taken 3. At what should have been the end of the process, last year, the board had to release an RNS to say a query had been raised, something which they didn't have to notify us about for the 'more challenging' EU submission. We have no idea when they submitted the data nor when we can expect a response back.

I didn't personally sense any excitement about impending news in the Annual Results. Instead, it felt more solemn, with focus now on having to raise more money to continue to try and pin down partners, something they have been telling us that they have been doing for nearly 2 years!

Most of us thought that these partner discussions should have been in a very advanced state by now. The fact that there are supposed to be 'multiple' partners should have added an element of competition to the situation, in our favour. The last hurdle should have been the FDA decision so that the board could finally choose which partner to go with.

Maybe its just more poor communication in the Annual Results RNS that has unnerved investors. Maybe, the board are so optimistic of a positive outcome that they have simply switched focus to raising funds to move forward with the next stage of collaboration, forgetting to reinforce their expectations of a positive outcome for the pending decision. Or, maybe they feel or know something different, preparing for the worst by having to raise funds to try and renegotiate something based on EMA approval alone.

I really hope it's not the latter and that the FDA hasn't been another wild goose chase that is about to cast a shadow on the success of the EU approval. The EU approval should have been enough to negotiate a deal on.

I don't know what is going to happen but I certainly don't find it hard to understand why we are at .2p instead of being north of .3p

"The company is informed first, then the public via the FDA website. So NFX should inform us by RNS before the news is published on the FDA website."

The actual EMA ratification (22nd April) occurred a week before the board released the RNS (29th April). I'm guessing they were informed on the same day it was ratified.

We got the fund raiser RNS first. Funnily enough, that was the same date as NXP002 was ratified.

I'll change when the company changes Whimax, that sound fair?

"It seems those eager to sell due to lack of FDA news have done so; next RNS must - surely - be the FDA one, so it's a coin toss from here on."

If the next RNS is a fund raiser then it is not good.

Why would Gooding raise funds first after the price has been smashed by todays RNS. We cannot be that far away from an FDA response being received (if it is not already known). If they expect it to be good they would wait for the price boost.

Same old same old.

Where have all the positive expectations of FDA ODD approval gone? Why is it taking so long?

The focus is now on raising more money to progress these 'partner discussions'! How on earth is it possible to progress them any more. They've been going for 2 years!!!

WHERE ARE THE PARTNERS?

Maybe someday

Maybe someday